title: Eltrombopag for thrombocytopenic patients with chronic HCV infection.
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
authors.forename: Raoel
authors.initials: R
authors.lastname: Maan
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
authors.forename: Bart J
authors.initials: BJ
authors.lastname: Veldt
authors.affiliation: Toronto Centre for Liver Disease, Toronto Western & General Hospital, University Health Network, Toronto, Canada; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
authors.forename: Harry L A
authors.initials: HL
authors.lastname: Janssen
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D006401:Hematologic Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D001565:Benzoates; D006401:Hematologic Agents; D006834:Hydrazines; D011720:Pyrazoles